Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Opportunities and challenges of herbal medicine

Phytotherapy in the fight against parasitic diseases

    • General Internal Medicine
    • Infectiology
    • Pharmaceutical medicine
    • Phytotherapy
    • RX
    • Studies
    • Tropical and travel medicine
  • 5 minute read

Modern medicine faces numerous challenges in the 21st century. One of the biggest is the increasing resistance of pathogens to conventional medicines, especially antibiotics and antiparasitics. Against this backdrop, herbal medicines, which have been used in traditional medicine for thousands of years, are becoming increasingly important.

(red) It is estimated that there are over 500,000 plant species worldwide, but less than one per thousand of these have been scientifically studied for their pharmacological properties. This points to the enormous potential that the plant world could still hold for the treatment of diseases – especially for combating parasitic diseases, which continue to pose a significant health threat worldwide.

The growing threat of parasitic diseases

Parasitic diseases are widespread worldwide and affect millions of people, especially in developing countries. Although living conditions are constantly improving in many regions of the world, parasitic infections remain a serious problem, which is exacerbated by the increasing resistance of pathogens to conventional drugs. This resistance means that many established therapies are losing their effectiveness and new treatment approaches are required. Phytotherapy, i.e. the use of medicinal plants and their extracts to treat diseases, offers a promising alternative here.

The therapeutic advantages of herbal active ingredients lie not only in their effectiveness, but also in their availability and cost-effectiveness. In contrast to synthetically produced medicines, which are often expensive to produce, herbal medicines can often be obtained locally and produced at a lower cost. In many regions of the world where access to modern medicine is limited, medicinal plants can therefore play an important role in healthcare.

Protozoan infections: Challenges and plant-based solutions

Protozoa are among the most widespread parasites and are responsible for a large number of serious diseases. Malaria, leishmaniasis and African sleeping sickness are among the best-known diseases caused by protozoa and continue to be serious health problems. The increasing resistance of protozoa to conventional drugs poses immense challenges for medicine. Phytotherapy offers promising approaches to develop new treatment options.

Malaria and artemisinin: a success of phytotherapy

One of the best known and most successful applications of phytotherapy is the treatment of malaria with artemisinin, an active ingredient extracted from the plant Artemisia annua, the annual mugwort. Malaria, caused by five different Plasmodium species, including Plasmodium falciparum and Plasmodium vivax, is still one of the deadliest parasitic diseases worldwide. Between 300 and 500 million people are infected with malaria every year, and despite medical progress, 1.5 to 2.7 million people die each year, mainly in sub-Saharan Africa.

Artemisinin, which is isolated from the plant Artemisia annua, has proven to be highly effective against malaria in clinical studies. Especially against Plasmodium falciparum, the most dangerous malaria pathogen, artemisinin showed a faster and more effective effect than previous drugs such as chloroquine. Artemisinin-based combination therapies (ACT) are now the recommended standard therapy against Plasmodium falciparum malaria. Compared to chloroquine, artemisinin eliminates the parasites faster, reduces the duration of the disease and the risk of relapse. This has made artemisinin a cornerstone in the treatment of malaria, especially in areas with high resistance to conventional drugs.

Despite these successes, the challenge remains that Plasmodium species can develop resistance, as has already been the case with other malaria drugs. Research is therefore being carried out worldwide into further plant-based alternatives. A number of plants that are traditionally used against malaria in countries such as Ethiopia or Vietnam are currently being intensively investigated in order to identify new antimalarial agents. For example, Rhaphidophora decursiva , a creeping shrub native to Vietnam, shows promising antimalarial properties, although the side effects, such as the observed cytotoxicity, still need to be researched further.

African sleeping sickness and herbal treatment options

African sleeping sickness, also known as African trypanosomiasis, is another protozoan infection caused by the parasite Trypanosoma brucei (Fig. 1). Transmitted by the bite of the tsetse fly, the disease affects thousands of people every year, especially in rural areas of Africa. If left untreated, African sleeping sickness almost always leads to death. The disease progresses in two stages: in the early stage, fever, headaches and joint pain occur, while in the late stage the parasites attack the central nervous system and lead to neurological symptoms and even coma.

The treatment of African sleeping sickness is complicated, as the available drugs are toxic and have severe side effects. In addition, many parasite strains are resistant to common drugs. Phytotherapy could play an important role here. Studies on mice have shown that an extract of the plant Artemisia abyssinica, which is native to Ethiopia, has a promising effect against Trypanosoma brucei. The extract not only reduced the parasite load in the body, but also improved the general condition of the infected animals by alleviating anemia and strengthening the immune response.

Another example of herbal treatments is the Ocimum gratissimum plant, whose extracts also showed a significant reduction in the parasite load in trypanosomiasis. This plant, which is native to Africa and Asia, has strong trypanicidal properties and could play an important role in the treatment of sleeping sickness in the future.

Leishmaniasis: a neglected but deadly disease

Leishmaniasis is a tropical parasitic disease caused by protozoa of the genus Leishmania. Although it is the second deadliest parasitic infection after malaria, it is often neglected because it occurs mainly in the poorest regions of the world. About 2 million new cases of leishmaniasis are reported each year and about 12 million people suffer from the disease. Leishmaniasis occurs in three main forms: cutaneous (skin), mucocutaneous (mucous membranes) and visceral (internal organs).

The treatment of leishmaniasis is difficult as many of the drugs used are toxic and expensive. In addition, increasingly resistant parasite strains have developed in recent years. However, phytotherapy offers promising alternatives. Numerous plant extracts, including those from Yucca filamentosa and Picrorhiza kurroa, have shown strong antileishmanial properties in studies. These plants could serve as the basis for new, less toxic treatments in the future.

Particularly promising are extracts from the plant Annona haematantha, whose main ingredient, the lactone argentilactone, has been shown in clinical studies to reduce parasite loads by up to 96%. However, further research is needed to confirm the efficacy and safety of these herbal treatments.

Worm diseases: Herbal approaches to combating helminthoses

In addition to protozoa, worm diseases, so-called helminthoses, also pose a considerable threat to health. Diseases caused by roundworms, tapeworms and liver flukes are particularly widespread. These parasites affect not only humans but also animals and cause high health costs worldwide.

Fasciolosis and schistosomiasis: plant extracts as an alternative

Fasciolosis, a disease caused by liver flukes of the genus Fasciola, affects millions of people and animals worldwide. Infection usually occurs through the consumption of contaminated plants or water. In phytotherapy, myrrh (Commiphora myrrha) has proven to be an effective remedy against these parasites. Myrrh damages the shell of the parasites, making it easier to kill them.

Another example is schistosomiasis, one of the most common parasitic infections worldwide, which is particularly prevalent in tropical areas of Africa and Asia. The disease caused by schistosomes affects millions of people every year. Here too, phytotherapy is showing promising results. Plants such as Origanum majorana (marjoram, Fig. 2), Ziziphus spina-christi (Christ’s thorn) and Salvia fructicosa (shrub sage) have shown antiparasitic effects in studies.

Conclusion

Phytotherapy is a promising alternative for the treatment of parasitic diseases, especially in times of increasing resistance to synthetic drugs. Plant extracts not only offer a more cost-effective production method, but have also been shown to be effective in numerous studies. Nevertheless, the challenge remains to further research their safety and efficacy and to develop standardized treatment protocols. Given the growing global health threat posed by parasites, the research and use of medicinal plants could play an increasingly important role in global healthcare in the future.

Source: Kluj A, Kosiada M, Mularczyk P, et al: The use of phytotherapy in the fight against parasitic diseases. Ann Parasitol. 2023; 69(3-4): 91-102. doi: 10.17420/ap6903/4.513. PMID: 38281734.

PHYTOTHERAPY PRACTICE 2024; 1(1): 9-10

Publikation
  • PHYTOTHERAPIE PRAXIS
Related Topics
  • Fasciolosis
  • Leishmaniasis
  • Malaria
  • roundworm
  • Schistosomiasis
  • sleeping sickness
  • Tropical Diseases
  • Trypanosoma brucei
  • worm infestation
Previous Article
  • Fungal infections of the lungs

Three approaches to reduce P. jirovecii mortality

  • Education
  • Infectiology
  • Pneumology
  • RX
  • Studies
View Post
Next Article
  • Anticoagulation for atrial fibrillation

New ESC guideline has adapted recommendations

  • RX
  • Cardiology
  • Congress Reports
  • General Internal Medicine
  • Studies
View Post
You May Also Like
View Post
  • 5 min
  • Anxiety disorders

New study on lavender oil extract in a long-term setting

    • RX
    • Education
    • General Internal Medicine
    • Pharmaceutical medicine
    • Phytotherapy
    • Psychiatry and psychotherapy
    • Studies
View Post
  • 12 min
  • Evidence, effectiveness and practical implications

Medicinal plants for allergic rhinitis

    • RX
    • Allergology and clinical immunology
    • Education
    • General Internal Medicine
    • ORL
    • Pharmaceutical medicine
    • Phytotherapy
    • Studies
View Post
  • 15 min
  • Current status and future prospects

Cell and gene therapies in modern cardiology

    • Cardiology
    • Education
    • Genetics
    • RX
    • Studies
View Post
  • 14 min
  • Patient-oriented recommendations for action

Effect of heat on diabetes technology

    • RX
    • CME continuing education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Prevention and health care
    • Studies
View Post
  • 19 min
  • Cardiovascular risk and obesity

Pathomechanisms, secondary prevention and treatment options

    • RX
    • Cardiology
    • CME continuing education
    • Endocrinology and Diabetology
    • Nutrition
    • Sports Medicine
    • Studies
    • Training with partner
View Post
  • 6 min
  • Ventricular arrhythmias

Indication for ICD or WCD?

    • RX
    • Cardiology
    • Congress Reports
    • General Internal Medicine
    • Studies
View Post
  • 3 min
  • Early breast cancer

Overweight and obesity worsen the prognosis

    • Congress Reports
    • Gynecology
    • Oncology
    • Prevention and health care
    • RX
    • Studies
View Post
  • 8 min
  • Psoriasis treatment with biologics

What are the latest trends?

    • Congress Reports
    • Dermatology and venereology
    • Pharmacology and toxicology
    • Rheumatology
    • RX
    • Studies
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Pathomechanisms, secondary prevention and treatment options
  • 2
    Effect of heat on diabetes technology
  • 3
    Improved quality of care aims for satisfied patients
  • 4
    Dr. ChatGPT: Large language models in everyday clinical practice
  • 5
    Examinations and considerations before therapy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.